5 completed, 1 terminated, 1 unknown. 4 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
Follow Insulin Hypoglycemia: new trials by email Literature Review of Insulin Hypoglycemia trials Research Report on Insulin Hypoglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blood Glucose Management in Intensive Care Units Insulin - Insulin Hypoglycemia, Glucose Test Site Bleeding | Unknown | French Society for Intensive Care | 525 | 2023-03-20 | 2023-04-06 | |
| Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes Stepped hyperinsulinaemic-hypoglycaemic clamp study, Insulin pump, Continuous glucose monitor - Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia | Not applicable | Completed | University of Edinburgh | 24 | 2021-07-26 | 2026-01-28 |
| CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia use of continuous glucose monitoring - Hypoglycemia, Reactive, Hypoglycaemia Night | Not applicable | Terminated | Barts & The London NHS Trust | 7 | 2019-12-01 | 2023-12-12 |
| Effects of Frequency and Duration of Exercise in People With Type 1 Diabetes A Randomized Crossover Study "Five sessions per period" - "Two sessions per period", "Two sessions per period" - "Five sessions per period" - Diabetes Mellitus, Type 1, Insulin Hypoglycemia | Not applicable | Completed | Steno Diabetes Center Copenhagen | 26 | 2019-09-30 | 2021-09-28 |
| G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes G-Pen, Novo Glucagon - Insulin Hypoglycemia, Type 1 Diabetes Mellitus | Phase 3 | Completed | Xeris Pharmaceuticals | 132 | 2018-09-27 | 2020-05-22 |
| G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes G-Pen, Lilly Glucagon - Insulin Hypoglycemia, Type 1 Diabetes Mellitus | Phase 3 | Completed | Xeris Pharmaceuticals | 81 | 2018-01-23 | 2020-02-17 |
| Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment Algorithm-based feedback messages, Personal Health Record - Diabetes Mellitus, Insulin Hypoglycemia | Not applicable | Completed | Samsung Medical Center | 112 | 2017-09-26 | 2019-04-05 |
Diabetes Mellitus, Type 1 (5) · Hypoglycemia (4) · Insulin Resistance (3) · Diabetes Mellitus (1) · Hyperglycemia (1) · Insulinoma (1) · Motor Activity (1)
Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Endocrine System Diseases (6) · Autoimmune Diseases (5) · Immune System Diseases (5) · Diabetes Mellitus (4) · Hyperinsulinism (3) · Adenoma (1) · Adenoma, Islet Cell (1) · Behavior (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Neoplasms (1)
Glucagon (2) · Diet, Carbohydrate-Restricted (1) · Health Records, Personal (1) · Insulin (1) · Insulin Infusion Systems (1)
Xeris Pharmaceuticals (2) · Barts & The London NHS Trust (1) · French Society for Intensive Care (1) · Samsung Medical Center (1) · Steno Diabetes Center Copenhagen (1) · University of Edinburgh (1)
Canada (2) · United Kingdom (2) · United States (2) · Austria (1) · Denmark (1) · France (1) · South Korea (1)
Isabelle IK Steineck, MD (1) · Laurent Papazian (1) · Sang-Man Jin, MD PhD (1) · Shareen Forbes, MBChB, PhD (1)
PMID 28720103, PMID 33509935, PMID 34620618, PMID 35322535, PMID 36600427